1例恶性水肿型皮肤炭疽患者的药学监护

袁海玲; 谢华<sup>*</sup>; 魏国一; 赵静; 路宁维; 张文

引用本文:	袁海玲,谢华,魏国一,赵静,路宁维,张文.1例恶性水肿型皮肤炭疽患者的药学监护[J].中国现代应用药学,2016,33(5):660-664.
	YUAN Hailing,XIE Hua,WEI Guoyi,ZHAO Jing,LU Ningwei,ZHANG Wen.Pharmaceutical Care for a Patient with Cutaneous Anthrax of Malignant Edema[J].Chin J Mod Appl Pharm(中国现代应用药学),2016,33(5):660-664.

【打印本页】【HTML】【下载PDF全文】【查看/发表评论】【EndNote】【RefMan】【BibTex】

←前一篇|后一篇→

过刊浏览高级检索

本文已被：浏览 1992次下载 1410次	码上扫一扫！
分享到：微信更多字体:加大+\|默认\|缩小-
1例恶性水肿型皮肤炭疽患者的药学监护
袁海玲¹, 谢华², 魏国一³, 赵静⁴, 路宁维⁵, 张文⁶
1.兰州军区兰州总医院安宁分院药剂科，兰州 730070;2.兰州军区兰州总医院安宁分院药剂科，兰州 730071;3.兰州军区兰州总医院安宁分院药剂科，兰州 730072;4.兰州军区兰州总医院安宁分院药剂科，兰州 730073;5.兰州军区兰州总医院安宁分院药剂科，兰州 730074;6.兰州军区兰州总医院安宁分院药剂科，兰州 730075

摘要:

目的探讨临床药师对恶性水肿型皮肤炭疽患者的药学监护模式。方法根据恶性水肿型皮肤炭疽患者的药物治疗特点，对患者进行药学监护，针对性提出用药建议。结果通过药学监护，可提高恶性水肿型皮肤炭疽患者用药的安全性、合理性及有效性，减少药物不良反应的发生。结论临床药师积极开展药学服务，协同临床医师优化给药方案，有利于患者用药安全、合理、有效。

关键词: 皮肤炭疽临床药师药学监护

DOI：

分类号:

基金项目:

Pharmaceutical Care for a Patient with Cutaneous Anthrax of Malignant Edema

YUAN Hailing¹, XIE Hua², WEI Guoyi³, ZHAO Jing⁴, LU Ningwei⁵, ZHANG Wen⁶

1.Department of Pharmacy, Anning Branch Lanzhou General Hospital Lanzhou Command, Lanzhou 730070, China;2.Department of Pharmacy, Anning Branch Lanzhou General Hospital Lanzhou Command, Lanzhou 730071, China;3.Department of Pharmacy, Anning Branch Lanzhou General Hospital Lanzhou Command, Lanzhou 730072, China;4.Department of Pharmacy, Anning Branch Lanzhou General Hospital Lanzhou Command, Lanzhou 730073, China;5.Department of Pharmacy, Anning Branch Lanzhou General Hospital Lanzhou Command, Lanzhou 730074, China;6.Department of Pharmacy, Anning Branch Lanzhou General Hospital Lanzhou Command, Lanzhou 730075, China

Abstract:

OBJECTIVE To discuss the pharmaceutical care model on the patient with cutaneous anthrax of malignant edema. METHODS According to the characteristics of drug therapy on the patient with cutaneous anthrax of malignant edema, the pharmaceutical care was carried out and the suggestions on the pharmacy were given. RESULTS Through the pharmaceutical care, the safety, reasonable and effectiveness were improved. And also, the incidence rate of adverse drug reaction was decreased. CONCLUSION The clinical pharmacists develop actively pharmaceutical service and optimize dosage regimen cooperating with the clinical physician, which is beneficial to the safety, reasonable and effectiveness of drug therapy on the patients.

Key words: cutaneous anthrax clinical pharmacist pharmaceutical care